• LAST PRICE
    3.6700
  • TODAY'S CHANGE (%)
    Trending Down-0.1600 (-4.1775%)
  • Bid / Lots
    3.5000/ 2
  • Ask / Lots
    4.5500/ 13
  • Open / Previous Close
    3.7600 / 3.8300
  • Day Range
    Low 3.5000
    High 3.9100
  • 52 Week Range
    Low 2.4400
    High 8.8400
  • Volume
    228,175
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 3.83
TimeVolumeGLUE
09:32 ET24253.76
09:36 ET1983.73
09:38 ET14843.72
09:41 ET10773.71
09:43 ET4003.76
09:45 ET1003.75
09:48 ET1003.75
09:50 ET1003.78
09:52 ET2003.79
09:56 ET1003.79
09:57 ET6003.79
10:01 ET4003.91
10:06 ET17703.77
10:10 ET5953.74
10:12 ET16663.65
10:14 ET15303.62
10:15 ET5503.665
10:17 ET5003.64
10:19 ET3223.63
10:21 ET9053.625
10:24 ET9003.64
10:26 ET6303.615
10:30 ET1503.615
10:32 ET238333.555
10:33 ET77073.59
10:35 ET4953.59
10:37 ET5993.64
10:42 ET1003.64
10:44 ET5003.605
10:57 ET6063.69
11:00 ET6493.7
11:02 ET4003.69
11:04 ET1003.64
11:06 ET1003.64
11:08 ET2003.645
11:11 ET4383.63
11:13 ET1003.62
11:15 ET1003.67
11:18 ET2333.59
11:20 ET4003.6
11:24 ET5003.635
11:26 ET3463.6101
11:27 ET3823.61
11:31 ET7003.58
11:33 ET1003.57
11:36 ET2003.57
11:38 ET1003.55
11:40 ET2003.55
11:42 ET3003.56
11:44 ET6703.575
11:47 ET1003.55
11:51 ET2003.54
11:56 ET6793.5662
11:58 ET6463.57
12:00 ET2003.56
12:02 ET3213.55
12:05 ET4003.54
12:09 ET3053.58
12:16 ET30623.565
12:18 ET3003.56
12:20 ET3003.565
12:21 ET6003.55
12:23 ET1003.58
12:27 ET2053.54
12:30 ET3003.59
12:32 ET6033.58
12:34 ET8473.59
12:36 ET1003.58
12:38 ET4003.6
12:39 ET1003.56
12:43 ET1003.6
12:48 ET8413.56
12:50 ET5003.54
12:52 ET7443.555
12:54 ET2003.56
12:57 ET5663.56
01:01 ET1703.545
01:03 ET5303.57
01:06 ET1003.6
01:08 ET1003.59
01:10 ET3003.58
01:12 ET2003.59
01:14 ET41713.585
01:15 ET2003.57
01:17 ET1003.57
01:19 ET1003.57
01:24 ET1003.58
01:26 ET1623.56
01:28 ET30103.56
01:30 ET2413.57
01:32 ET2003.55
01:35 ET1713.54
01:37 ET3003.535
01:39 ET8023.53
01:46 ET1003.52
01:48 ET1003.53
01:51 ET2163.52
01:53 ET1003.52
01:55 ET1003.52
01:57 ET14303.53
02:02 ET1003.51
02:04 ET3003.5475
02:08 ET17703.585
02:11 ET6503.59
02:13 ET2003.61
02:15 ET7813.57
02:18 ET1003.6
02:22 ET1003.6
02:24 ET82543.58
02:26 ET9003.58
02:27 ET2003.58
02:29 ET6003.59
02:31 ET1003.6
02:33 ET1003.58
02:36 ET2003.6
02:38 ET1003.58
02:40 ET22003.615
02:42 ET1003.65
02:45 ET1003.64
02:49 ET2003.65
02:54 ET26003.63
02:56 ET1003.62
02:58 ET1003.64
03:00 ET1003.62
03:03 ET7003.62
03:05 ET4003.64
03:07 ET1003.61
03:14 ET60003.64
03:16 ET1003.61
03:18 ET1923.6001
03:20 ET36003.625
03:21 ET21723.6275
03:23 ET5003.67
03:25 ET4003.66
03:27 ET1003.65
03:30 ET31053.65
03:32 ET7693.67
03:34 ET2003.65
03:36 ET181083.615
03:38 ET1003.61
03:39 ET1213.61
03:41 ET2003.61
03:43 ET2003.62
03:45 ET4003.62
03:48 ET2003.61
03:50 ET1003.605
03:52 ET33443.65
03:54 ET22833.68
03:56 ET37223.69
03:57 ET54313.7
03:59 ET281203.67
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLUE
Monte Rosa Therapeutics Inc
233.0M
-1.5x
---
United StatesFBLG
Fibrobiologics Inc
232.6M
-6.5x
---
United StatesATNM
Actinium Pharmaceuticals Inc
232.9M
-4.6x
---
United StatesOMER
Omeros Corp
235.3M
-1.4x
---
United StatesOVID
Ovid Therapeutics Inc
233.4M
-1.1x
---
United StatesEPIX
ESSA Pharma Inc
238.2M
-7.8x
---
As of 2024-06-17

Company Information

Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and more. MGDs are small molecule drugs that employ the body’s natural protein destruction mechanisms to selectively degrade therapeutically relevant proteins. It has developed a degradation platform, called Quantitative and Engineered Elimination of Neosubstrates (QuEEN) to enable its target centric MGD discovery and development approach and its rational design of MGD product candidates. Its product candidate, MRT-2359, is an orally bioavailable MGD targeting the translation termination factor protein GSPT1. MRT-2359 is in clinical development for potential use in MYC-driven tumors, including metastatic non-small cell lung cancer, small cell lung cancer and neuroendocrine tumors. Its other product candidates include MRT-6160 and MRT-8102.

Contact Information

Headquarters
321 Harrison Avenue, Suite 900BOSTON, MA, United States 02118
Phone
617-949-2643
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
Andrew Schiff
President, Chief Executive Officer, Director
Markus Warmuth
Chief Operating Officer
Jennifer Champoux
Chief Scientific Officer
Sharon Townson
Chief Medical Officer
Filip Janku

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$233.0M
Revenue (TTM)
$1.1M
Shares Outstanding
60.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.53
Book Value
$3.57
P/E Ratio
-1.5x
Price/Sales (TTM)
219.0
Price/Cash Flow (TTM)
---
Operating Margin
-13,533.74%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.